FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

385231004: Powder for infusion solution (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    1479488012 Powder for infusion solution en Synonym Active Entire term case insensitive SNOMED CT core module
    2660103012 Powder for infusion solution (qualifier value) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    52282301000001119 Powder for solution for infusion en Synonym Active Entire term case sensitive SNOMED CT United Kingdom Edition module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Powder for infusion solution Is a Type of drug preparation false Inferred relationship Existential restriction modifier
    Powder for infusion solution Is a Drug powder false Inferred relationship Existential restriction modifier
    Powder for infusion solution Is a Powder for reconstitution for drug product false Inferred relationship Existential restriction modifier
    Powder for infusion solution Is a Parenteral dose form false Inferred relationship Existential restriction modifier
    Powder for infusion solution Is a Infusion powder false Inferred relationship Existential restriction modifier
    Powder for infusion solution Has state of matter Solid false Inferred relationship Existential restriction modifier
    Powder for infusion solution Has dose form intended site Parenteral false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Topotecan 4mg powder for solution for infusion vials (Actavis UK Ltd) Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Topotecan 1mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd) Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Topotecan 4mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd) Has manufactured dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Topotecan 4mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd) Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Topotecan 1mg powder for solution for infusion vials (Actavis UK Ltd) 1 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Topotecan 4mg powder for solution for infusion vials (Actavis UK Ltd) 1 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Topotecan 1mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd) 1 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Topotecan 4mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd) 1 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Hydroxocobalamin 5g powder for solution for infusion vials Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Cyanokit 5g powder for solution for infusion vials (Swedish Orphan Biovitrum Ltd) Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Hydroxocobalamin 5g powder for solution for infusion vials 1 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Cyanokit 5g powder for solution for infusion vials (Swedish Orphan Biovitrum Ltd) 1 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Gemcitabine 2g powder for solution for infusion vials (Accord Healthcare Ltd) Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Gemcitabine 1g powder for solution for infusion vials (Accord Healthcare Ltd) Has manufactured dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Gemcitabine 1g powder for solution for infusion vials (Accord Healthcare Ltd) Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Gemcitabine 200mg powder for solution for infusion vials (Accord Healthcare Ltd) Has manufactured dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Gemcitabine 200mg powder for solution for infusion vials (Accord Healthcare Ltd) Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Gemcitabine 2g powder for solution for infusion vials (Accord Healthcare Ltd) 1 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Gemcitabine 1g powder for solution for infusion vials (Accord Healthcare Ltd) 1 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Gemcitabine 200mg powder for solution for infusion vials (Accord Healthcare Ltd) 1 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Dacarbazine 500mg powder for solution for injection vials (Medac GMBH) Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Dacarbazine 600mg powder for solution for injection vials (Mayne Pharma Plc) Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Dacarbazine 1g powder for solution for injection vials (Medac GMBH) Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Dacarbazine 600mg powder for solution for injection vials 1 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Dacarbazine 600mg powder for solution for injection vials (Mayne Pharma Plc) 1 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Dacarbazine 1g powder for solution for injection vials 1 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Dacarbazine 500mg powder for solution for injection vials 1 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Dacarbazine 1g powder for solution for injection vials (Medac GMBH) 1 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Dacarbazine 500mg powder for solution for injection vials (Medac GMBH) 1 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Digoxin-specific antibody fragments 40mg powder for solution for infusion vials Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    DigiFab 40mg powder for solution for infusion vials (Protherics Medicines Development Ltd) Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Digoxin-specific antibody fragments 40mg powder for solution for infusion vials 1 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    DigiFab 40mg powder for solution for infusion vials (Protherics Medicines Development Ltd) 1 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Digoxin-specific antibody fragments 38mg powder for solution for injection vials Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Digoxin-specific antibody fragments 38mg powder for solution for injection vials 1 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Digibind 38mg powder for solution for injection vials (GlaxoSmithKline) Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Digibind 38mg powder for solution for injection vials (GlaxoSmithKline) 1 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Biofactor Streptokinase 250,000unit powder for solution for infusion vials (Beacon Pharmaceuticals Ltd) Has manufactured dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Biofactor Streptokinase 250,000unit powder for solution for infusion vials (Beacon Pharmaceuticals Ltd) Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Biofactor Streptokinase 750,000unit powder for solution for infusion vials (Beacon Pharmaceuticals Ltd) Has manufactured dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Biofactor Streptokinase 750,000unit powder for solution for infusion vials (Beacon Pharmaceuticals Ltd) Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Biofactor Streptokinase 1.5million unit powder for solution for infusion vials (Beacon Pharmaceuticals Ltd) Has manufactured dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Biofactor Streptokinase 1.5million unit powder for solution for infusion vials (Beacon Pharmaceuticals Ltd) Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Biofactor Streptokinase 250,000unit powder for solution for infusion vials (Beacon Pharmaceuticals Ltd) 1 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Biofactor Streptokinase 750,000unit powder for solution for infusion vials (Beacon Pharmaceuticals Ltd) 1 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Biofactor Streptokinase 1.5million unit powder for solution for infusion vials (Beacon Pharmaceuticals Ltd) 1 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Amphotericin B liposomal 50mg powder for dispersion for infusion vials Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Amphotericin B sodium cholesteryl sulphate complex 100mg powder for solution for infusion vials Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Amphotericin B sodium cholesteryl sulphate complex 50mg powder for solution for infusion vials Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Amphocil 100mg powder for solution for infusion vials (Beacon Pharmaceuticals Ltd) Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    AmBisome Liposomal 50mg powder for dispersion for infusion vials (Gilead Sciences Ltd) Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Amphocil 50mg powder for solution for infusion vials (Beacon Pharmaceuticals Ltd) Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Amphotericin B sodium cholesteryl sulphate complex 50mg powder for solution for infusion vials 1 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Amphotericin B liposomal 50mg powder for dispersion for infusion vials 10 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Amphotericin B sodium cholesteryl sulphate complex 100mg powder for solution for infusion vials 1 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Amphocil 100mg powder for solution for infusion vials (Beacon Pharmaceuticals Ltd) 1 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    AmBisome Liposomal 50mg powder for dispersion for infusion vials (Gilead Sciences Ltd) 10 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Amphocil 50mg powder for solution for infusion vials (Beacon Pharmaceuticals Ltd) 1 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Topotecan 4mg powder for solution for infusion vials (Accord Healthcare Ltd) Has manufactured dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Topotecan 4mg powder for solution for infusion vials (Accord Healthcare Ltd) Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Topotecan 4mg powder for solution for infusion vials (Accord Healthcare Ltd) 1 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Ceftaroline fosamil 600mg powder for solution for infusion vials Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Zinforo 600mg powder for concentrate for solution for infusion vials (AstraZeneca UK Ltd) Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Ceftaroline fosamil 600mg powder for solution for infusion vials 10 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Zinforo 600mg powder for concentrate for solution for infusion vials (AstraZeneca UK Ltd) 10 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Pixantrone 29mg powder for solution for infusion vials Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Pixuvri 29mg powder for concentrate for solution for infusion vials (CTI Life Sciences Ltd) Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Pixantrone 29mg powder for solution for infusion vials 1 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Pixuvri 29mg powder for concentrate for solution for infusion vials (CTI Life Sciences Ltd) 1 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Brentuximab vedotin 50mg powder for solution for infusion vials Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Decitabine 50mg powder for solution for infusion vials Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Dacogen 50mg powder for concentrate for solution for infusion vials (Janssen-Cilag Ltd) Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Adcetris 50mg powder for concentrate for solution for infusion vials (Takeda UK Ltd) Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Brentuximab vedotin 50mg powder for solution for infusion vials 1 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Decitabine 50mg powder for solution for infusion vials 1 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Dacogen 50mg powder for concentrate for solution for infusion vials (Janssen-Cilag Ltd) 1 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Adcetris 50mg powder for concentrate for solution for infusion vials (Takeda UK Ltd) 1 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Ifosfamide 1g powder for concentrate for solution for injection vials (Alliance Healthcare (Distribution) Ltd) Has manufactured dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Ifosfamide 2g powder for concentrate for solution for injection vials (Alliance Healthcare (Distribution) Ltd) Has manufactured dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Fosfomycin 4g powder for solution for infusion vials Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Fosfoscina Intravenosa 4g powder for solution for infusion vials (Imported (Spain)) Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Fosfomycin 4g powder for solution for infusion vials 1 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Fosfoscina Intravenosa 4g powder for solution for infusion vials (Imported (Spain)) 1 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Ifosfamide 1g powder for solution for injection vials (A A H Pharmaceuticals Ltd) Has manufactured dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Epoprostenol 1.5mg powder for solution for infusion vials Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Epoprostenol 500microgram powder for solution for infusion vials Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Veletri 500microgram powder for solution for infusion vials (Janssen-Cilag Ltd) Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Veletri 1.5mg powder for solution for infusion vials (Janssen-Cilag Ltd) Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Epoprostenol 1.5mg powder for solution for infusion vials 1 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Epoprostenol 500microgram powder for solution for infusion vials 1 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Veletri 500microgram powder for solution for infusion vials (Janssen-Cilag Ltd) 1 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Veletri 1.5mg powder for solution for infusion vials (Janssen-Cilag Ltd) 1 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Ceftriaxone 2g powder for solution for infusion vials Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Ceftriaxone 2g powder for solution for infusion vials (Kent Pharmaceuticals Ltd) Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Ceftriaxone 2g powder for solution for infusion vials 1 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials 10 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) 10 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Ceftriaxone 2g powder for solution for infusion vials (Kent Pharma (UK) Limited) 1 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Product containing precisely azithromycin (as azithromycin dihydrate) 500 milligram/1 vial powder for conventional release solution for injection Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier
    Azithromycin 500mg powder for solution for injection vials 1 vial Has dispensed dose form False Powder for infusion solution Inferred relationship Existential restriction modifier

    Start Previous Page 7 of 13 Next End

    This concept is not in any reference sets

    Back to Start